Reacción #57384

ord-bce83af9c2454030b10934d6475f3838

Ecuación de reacción

[H-].[Na+]
sodium hydride
CCOC(C)=O.ClCCl
EA DCM
Cl.Nc1c(-c2ccc(C#Cc3ccccc3)s2)nc2cnccn12
2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-ylamine hydrochloride
Cl.Nc1c(-c2ccc(C#Cc3ccccc3)s2)nc2cnccn12
2-(5-Phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-ylamine hydrochloride
CCBr
ethyl bromide
CCNc1c(-c2ccc(C#Cc3ccccc3)s2)nc2cnccn12
ethyl-[2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-yl]-amine
Rendimiento 92.5%

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGThe reaction solution was stirred at RT for 16 h
  2. 2
    Otroquenched with water (10 ml)
  3. 3
    Extracciónextracted with EA (2×50 ml)
  4. 4
    SecadoThe combined organic phases were dried over MgSO4
  5. 5
    Filtraciónfiltered
  6. 6
    Otroevaporated under a vacuum

Procedimiento

395 mg (1.25 mmol) of 2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-ylamine hydrochloride (Example 83) were dissolved in DMF (8 ml). After addition of 100 mg (2.5 mmol) of sodium hydride (60% dispersion in mineral oil), the mixture was stirred at RT for 1 h. A solution of 74 μl (0.8 mmol) of ethyl bromide in DMF (2 ml) was then added dropwise. The reaction solution was stirred at RT for 16 h, quenched with water (10 ml) and extracted with EA (2×50 ml). The combined organic phases were dried over MgSO4, filtered and evaporated under a vacuum. 253 mg (0.74 mmol, 58% of theoretical) of ethyl-[2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-yl]-amine were obtained by means of column chromatography (silica gel, EA/DCM 4:1).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07420056B2uspto-grants-2008_09